Comparison of pituitary adenylate cyclase-activating polypeptide (PACAP, ADCYAP1) gene polymorphisms among patients with methamphetamine addiction, methamphetamine-induced psychosis and healthy controls

[1]  K. Ressler,et al.  Circulating PACAP peptide and PAC1R genotype as possible transdiagnostic biomarkers for anxiety disorders in women: a preliminary study , 2020, Neuropsychopharmacology.

[2]  M. Bouton,et al.  Pituitary Adenylate Cyclase-Activating Peptide in the Bed Nucleus of the Stria Terminalis Mediates Stress-Induced Reinstatement of Cocaine Seeking in Rats , 2018, Neuropsychopharmacology.

[3]  W. Dragan,et al.  PAC1 receptor (ADCYAP1R1) genotype and problematic alcohol use in a sample of young women , 2017, Neuropsychiatric disease and treatment.

[4]  R. Hashimoto,et al.  Implications of PACAP Signaling in Psychiatric Disorders , 2016 .

[5]  M. Tohyama,et al.  Molecular basis of major psychiatric diseases such as schizophrenia and depression , 2015, Anatomical Science International.

[6]  T. Vos,et al.  The global epidemiology and burden of psychostimulant dependence: findings from the Global Burden of Disease Study 2010. , 2014, Drug and alcohol dependence.

[7]  K. Rickels,et al.  Genetic polymorphisms in the PACAP and PAC1 receptor genes and treatment response to venlafaxine XR in generalized anxiety disorder , 2013, Psychiatry Research.

[8]  M. Herkenham,et al.  PACAP-deficient mice show attenuated corticosterone secretion and fail to develop depressive behavior during chronic social defeat stress , 2013, Psychoneuroendocrinology.

[9]  K. Silverman,et al.  Incentives and health: an introduction. , 2012, Preventive medicine.

[10]  T. Dóczi,et al.  Effect of PACAP in Central and Peripheral Nerve Injuries , 2012, International journal of molecular sciences.

[11]  J. Smoller,et al.  No association between ADCYAP1R1 and post-traumatic stress disorder in two independent samples , 2012, Molecular Psychiatry.

[12]  R. De La Garza,et al.  Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants. , 2010, Gender medicine.

[13]  J. Lönnqvist,et al.  Circadian clock gene polymorphisms in alcohol use disorders and alcohol consumption. , 2010, Alcohol and alcoholism.

[14]  M. Itokawa,et al.  Replication study of association between ADCYAP1 gene polymorphisms and schizophrenia , 2010, Psychiatric genetics.

[15]  Chris Cruickshank,et al.  A review of the clinical pharmacology of methamphetamine. , 2009, Addiction.

[16]  M. Tohyama,et al.  Regulation of pituitary adenylyl cyclase-activating polypeptide (PACAP, ADCYAP1: adenylyl cyclase-activating polypeptide 1) in the treatment of schizophrenia , 2008 .

[17]  W. Berrettini,et al.  Association analysis of the pituitary adenylate cyclase-activating polypeptide (PACAP/ADCYAP1) gene in bipolar disorder , 2008, Psychiatric genetics.

[18]  M. Iyo,et al.  The Dysbindin Gene (DTNBP1) Is Associated with Methamphetamine Psychosis , 2008, Biological Psychiatry.

[19]  D. Weinberger,et al.  Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia , 2007, Molecular Psychiatry.

[20]  M. Tohyama,et al.  A novel DISC1-interacting partner DISC1-Binding Zinc-finger protein: implication in the modulation of DISC1-dependent neurite outgrowth , 2007, Molecular Psychiatry.

[21]  W. Honer,et al.  The need for speed: an update on methamphetamine addiction. , 2006, Journal of psychiatry & neuroscience : JPN.

[22]  M. Schuckit.  Comorbidity between substance use disorders and psychiatric conditions. , 2006, Addiction.

[23]  M. Iyo,et al.  Positive association of AKT1 haplotype to Japanese methamphetamine use disorder. , 2005, The international journal of neuropsychopharmacology.

[24]  Ivan Nikolov,et al.  Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1) , 2005, Biological Psychiatry.

[25]  Xun Hu,et al.  Association analysis of the DRD4 and COMT genes in methamphetamine abuse , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[26]  K. Hashimoto,et al.  Association between the glutathione S‐transferase M1 gene deletion and female methamphetamine abusers , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[27]  M J Owen,et al.  Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). , 2004, Archives of general psychiatry.

[28]  K. Takahashi,et al.  Distribution, molecular characterization of pituitary adenylate cyclase-activating polypeptide and its precursor encoding messenger RNA in human and rat tissues. , 1993, The Journal of endocrinology.

[29]  M. Oshimura,et al.  Structure of the human pituitary adenylate cyclase activating polypeptide (PACAP) gene. , 1992, Biochimica et biophysica acta.